Europeanhhm

FDA Approves Novel Balloon Catheter for Vessel Occlusion in Patient Resuscitation

Friday, June 14, 2024

Emergency Scientific, a company based in Utah that specializes in medical devices for emergency medicine, has announced the first use of its Landmark REBOA Catheter in patient care.

This catheter is designed for resuscitative endovascular occlusion of the aorta (REBOA), a technique originally developed by the military to treat hemorrhage from non-compressible pelvic fractures and abdominal trauma, and has since been adopted by civilian healthcare providers.

REBOA is also used to treat conditions such as postpartum hemorrhage (PPH), cardiac arrest (CA), ruptured abdominal aortic aneurysms (AAA), and gastrointestinal (GI) bleeds.

Emergency medicine physician at the University of Utah who performed the first case, commented, "The Landmark Catheter was easy to use and deploy with smooth insertion.

REBOA can be a critical tool in patient resuscitation." Traumatic hemorrhage is a leading cause of death in the United States, accounting for more than 60,000 deaths annually among individuals under 45 years old.

They are pleased to offer physicians another solution for managing challenging emergency hemorrhages.

Through innovative emergency medicine solutions, we aim to save more lives from life-threatening injuries. Our goal is to prevent avoidable deaths from blood loss with the right tools, and we are committed to providing novel treatment options to our healthcare partners.

The Landmark REBOA Catheter recently received FDA 510(k) clearance and is intended for temporary occlusion of large vessels in patients requiring emergency hemorrhage control.

Emergency Scientific is a privately held company focused on developing, manufacturing, and distributing innovative emergency medicine solutions.








Source: prnewswire.com

Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital Congress